Back to User profile » Dr Ying-Ming Tsai

Papers published by Dr Ying-Ming Tsai:

Original Research

Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment

Yang CJ, Tsai MJ, Hung JY, Liu TC, Chou SH, Lee JY, Hsu JS, Tsai YM, Huang MS, Chong IW

OncoTargets and Therapy 2016, 9:1579-1587

Published Date: 16 March 2016

Original Research

Poorer prognosis in Taiwanese female ever smokers with stage IV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor

Yang CJ, Tsai MJ, Hung JY, Tsai YM, Lee JY, Chou SH, Liu TC, Shen MC, Huang MS, Chong IW

OncoTargets and Therapy 2016, 9:1511-1518

Published Date: 15 March 2016